Predictive value of next-generation sequencing-based measurable residual disease quantitative stratification for early disease progression in newly diagnosed multiple myeloma after induction therapy

Zhonghua Xue Ye Xue Za Zhi. 2026 Jul 14;47(7):667-675. doi: 10.3760/cma.j.cn121090-20260403-00173.ABSTRACTObjective: To evaluate the predictive value of next-generation sequencing (NGS) -based quantitative minimal residual disease (MRD) stratification for early disease progression in patients newly

Y Y H Peng

The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma

Zhonghua Xue Ye Xue Za Zhi. 2026 Jun 14;47(6):582-586. doi: 10.3760/cma.j.cn121090-20260115-00028.ABSTRACTThe clinical data of 57 patients with multiple myeloma (MM) who underwent autologous hematopoietic stem cell transplantation (auto-HSCT) at the Second Affiliated Hospital of Anhui Medical Univer

L L L Zhang

Approach to Urticaria and Angioedema in the Older Patient

J Allergy Clin Immunol Pract. 2026 Sep;14(9):1989-1997. doi: 10.1016/j.jaip.2026.05.038.ABSTRACTChronic spontaneous urticaria (CSU) and angioedema in the older population (typically >65 years) present unique diagnostic and management challenges due to physiological aging, frequent comorbidities, and

T Tukisa Smith

Intravascular large B-cell lymphoma with reversible central hypopituitarism

BMJ Case Rep. 2026 Sep 7;19(9):e274418. doi: 10.1136/bcr-2026-274418.ABSTRACTWe report the case of a woman in her late 60s who presented to our hospital with fever and general fatigue. Investigation revealed bicytopenia, splenomegaly and central hypothyroidism. Brain MRI revealed enlargement of the

R Ryuichiro Yamasaki